FDA finds good manufacturing practice violations at Sanofi Pasteur's vaccine production facility in France.
FDA has issued an untitled letter to Cangene citing current good manufacturing violations in its maunufacture of vaccines.
Merck's commitment to become less "U.S. centric" comes with rewards and benefits that include launching more new products in Europe. The company is also taking steps to mitigate the impact of austerity measures being implemented by many European countries.
